Publications by authors named "S Reisner"
HIV incidence among transgender women remains high and disproportionately impacts young, Black, and Latina transgender women. Data on preferred PrEP modalities among this population are limited. Participants in The LITE Cohort completed a survey module on PrEP modality preferences during 24-month study visits.
View Article and Find Full Text PDFBackground: Transgender women are a key population in the HIV epidemic globally, including in Peru. This cross-sectional epidemiological study characterized the pre-exposure prophylaxis (PrEP) cascade in adolescent and young adult transgender women in Peru to inform roll-out of early HIV prevention efforts.
Methods: Between February-July 2022, a community-recruited sample of HIV-negative or status unknown young transgender women ( = 140) in Peru completed a socio-behavioral survey and biological testing for HIV and bacterial STIs.
Article Synopsis
- The study investigated the prevalence of cardiac arrhythmias among transgender and nonbinary (TGNB) adults using medical records from a specialized care center over a period from 2010 to 2021.
- Out of 49,862 adults, 7121 identified as TGNB, showing a low prevalence of arrhythmias (ranging from 0.7% to 1.5%), with transgender individuals having similar odds of arrhythmias compared to cisgender men but higher odds compared to cisgender women.
- The findings suggest that the prevalence of arrhythmias is similar among TGNB adults regardless of whether they were undergoing gender-affirming hormone therapy (GAHT), highlighting the need for further research on this topic
Article Synopsis
- Cardiovascular disease is a major health issue for transgender women with HIV, partly influenced by factors like hormone therapy and psychosocial stress.
- A study analyzed data from 108 Black and Latina transgender women with HIV to investigate how stress affects CVD risk in relation to hormone therapy duration.
- Findings showed that while hormone therapy duration was linked to higher CVD risk, stress did not significantly impact this relationship, suggesting that age and overall physiological stress (measured by allostatic load) are more critical to CVD risk in this population.
Self-sampling for primary HPV detection for cervical cancer screening is now FDA-approved. Many persons interested in cervical cancer screening are eager to opt out of the invasive speculum exam and opt into the self-sampling. There is no limitation on which persons can choose self-sampling.
View Article and Find Full Text PDF